Prostate Cancer - What Is Cancer

Prostate Cancer

Pedro Barata, MD, on darolutamide efficacy across age subgroups

Pedro Barata, MD, on darolutamide efficacy across ...

4 days ago 9

NHS could offer a prostate cancer diagnosis within a day using AI

NHS could offer a prostate cancer diagnosis within...

5 days ago 5

Daiichi Sankyo’s Latest Clinical Trial: A Potential Game-Changer for Prostate Cancer Treatment

Daiichi Sankyo’s Latest Clinical Trial: A Potentia...

5 days ago 4

Boston Scientific’s Innovative SpaceIT Hydrogel System: A Game Changer in Prostate Cancer Treatment?

Boston Scientific’s Innovative SpaceIT Hydrogel Sy...

5 days ago 5

Amgen’s AMG 509 Study: A Potential Game-Changer in Prostate Cancer Treatment

Amgen’s AMG 509 Study: A Potential Game-Changer in...

5 days ago 3

Bayer’s Latest Prostate Cancer Study: A Potential Game-Changer?

Bayer’s Latest Prostate Cancer Study: A Potential ...

5 days ago 6

Procept Biorobotics’ WATER IV Study: A Game Changer in Prostate Cancer Treatment?

Procept Biorobotics’ WATER IV Study: A Game Change...

5 days ago 4

Pfizer’s Promising Phase 3 Study on Prostate Cancer Treatment: A Market Game-Changer?

Pfizer’s Promising Phase 3 Study on Prostate Cance...

5 days ago 3

Pfizer’s Latest Clinical Trial: A New Hope for Prostate Cancer Treatment

Pfizer’s Latest Clinical Trial: A New Hope for Pro...

5 days ago 3

Amgen’s New Prostate Cancer Study: A Potential Game-Changer?

Amgen’s New Prostate Cancer Study: A Potential Gam...

5 days ago 4

Amgen’s New Study on Xaluritamig: A Potential Game-Changer in Prostate Cancer Treatment?

Amgen’s New Study on Xaluritamig: A Potential Game...

5 days ago 2

Pfizer’s New Study: A Potential Game-Changer in Prostate Cancer Treatment?

Pfizer’s New Study: A Potential Game-Changer in Pr...

5 days ago 2

Bayer’s Innovative Approach in Prostate Cancer Treatment: A Phase 1 Study Update

Bayer’s Innovative Approach in Prostate Cancer Tre...

5 days ago 3

Hung Trinh: GSK Pens $357M Pact with French Biotech for Preclinical Prostate Cancer ADC

Hung Trinh: GSK Pens $357M Pact with French Biotec...

5 days ago 3

Bayer’s Darolutamide Study in India: A Potential Game-Changer for Prostate Cancer Treatment

Bayer’s Darolutamide Study in India: A Potential G...

5 days ago 2

Janux Therapeutics Advances Prostate Cancer Study with JANX007

Janux Therapeutics Advances Prostate Cancer Study ...

5 days ago 3

Bayer’s New Hope in Prostate Cancer: 225Ac-PSMA-Trillium Study Update

Bayer’s New Hope in Prostate Cancer: 225Ac-PSMA-Tr...

5 days ago 3

Pfizer’s Prostate Cancer Study: Long-term Safety and Market Impact

Pfizer’s Prostate Cancer Study: Long-term Safety a...

5 days ago 3

Vir Biotechnology’s Promising Prostate Cancer Study: A Potential Game-Changer?

Vir Biotechnology’s Promising Prostate Cancer Stud...

5 days ago 3

Annual Prostate Cancer Conference set for November 1 at Sandia Prep

Annual Prostate Cancer Conference set for November...

5 days ago 3

Hathal Haddad: Strengthening Global Cooperation to Tackle Prostate Cancer

Hathal Haddad: Strengthening Global Cooperation to...

5 days ago 2

Amgen’s Xaluritamig Trial: A Potential Game-Changer in Prostate Cancer Treatment

Amgen’s Xaluritamig Trial: A Potential Game-Change...

5 days ago 3

Oric Pharmaceuticals’ Promising Study on ORIC-944 for Metastatic Prostate Cancer

Oric Pharmaceuticals’ Promising Study on ORIC-944 ...

5 days ago 2

Pfizer and Astellas Study on Prostate Cancer Treatment: Key Insights for Investors

Pfizer and Astellas Study on Prostate Cancer Treat...

5 days ago 3

Clarity Pharmaceuticals Advances Prostate Cancer Diagnostic Study

Clarity Pharmaceuticals Advances Prostate Cancer D...

5 days ago 3

Clarity Pharmaceuticals’ Prostate Cancer Study: A Potential Breakthrough?

Clarity Pharmaceuticals’ Prostate Cancer Study: A ...

5 days ago 4

Clarity Pharmaceuticals Advances Prostate Cancer Imaging with New Phase 3 Study

Clarity Pharmaceuticals Advances Prostate Cancer I...

5 days ago 4

Astellas Pharma’s Promising Prostate Cancer Study: A Market Game Changer?

Astellas Pharma’s Promising Prostate Cancer Study:...

5 days ago 4

A 13-Year-Old Drug’s Persisting Power in Prostate Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

A 13-Year-Old Drug’s Persisting Power in Prostate ...

5 days ago 3

Biden warns of 'dark days' and urges Americans to stay optimistic

Biden warns of 'dark days' and urges Americans to ...

5 days ago 4

GSK buys prostate cancer drug rights for £268m

GSK buys prostate cancer drug rights for £268m

5 days ago 4

Simon Spohn: Great to be Part of the Annual Oncology Congress DGHO25 in Cologne

Simon Spohn: Great to be Part of the Annual Oncolo...

5 days ago 4

Triple meeting 2025 – Halda’s proximity play in prostate

Triple meeting 2025 – Halda’s proximity play in pr...

5 days ago 4

United States Prostate Cancer Biomarkers Market Research Report 2025-2033: Rising Disease Prevalence, Advanced Diagnostics, and Regional Adoption in States Like California, Texas, New York, Florida

United States Prostate Cancer Biomarkers Market Re...

5 days ago 4

GSK targets Syndivia’s prostate cancer ADC in £268m buy

GSK targets Syndivia’s prostate cancer ADC in £268...

5 days ago 3

Why some men don't respond to prostate cancer therapy

Why some men don't respond to prostate cancer ther...

5 days ago 3

New study at St. David’s aims to help men recover faster after prostate cancer

New study at St. David’s aims to help men recover ...

5 days ago 4

Biden speaks publicly after cancer treatment

Biden speaks publicly after cancer treatment

5 days ago 4

Biden calls these 'dark days' as he urges Americans to 'get back up'

Biden calls these 'dark days' as he urges American...

5 days ago 4

ORIC Pharmaceuticals Presents ORIC-944 Preclinical Data at EORTC-NCI-AACR Conference, Highlighting Potential in Treating Prostate Cancer and Other Solid Tumors

ORIC Pharmaceuticals Presents ORIC-944 Preclinical...

5 days ago 4

ORIC® Pharmaceuticals Presented Preclinical Data at the EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics Supporting Best-in-Class Potential of ORIC-944 to Treat Patients With Prostate Cancer and Other Solid Tumors

ORIC® Pharmaceuticals Presented Preclinical Data a...

5 days ago 4

GSK acquires exclusive rights from Syndivia for ADC in prostate cancer

GSK acquires exclusive rights from Syndivia for AD...

5 days ago 4

Could A Specificity Emphasis for MRI-Based T-Staging Reinvent Staging for Prostate Cancer?

Could A Specificity Emphasis for MRI-Based T-Stagi...

2 months ago 65

UChicago Medicine emerges as a global leader in focal therapy treatments for prostate cancer

UChicago Medicine emerges as a global leader in fo...

2 months ago 60

Bristol Myers Squibb's Strategic Radiopharma Expansion: Unlocking Prostate Cancer Market Potential via the OncoACP3 Deal

Bristol Myers Squibb's Strategic Radiopharma Expan...

2 months ago 68

Artera receives FDA de novo authorization for prostate cancer diagnosis

Artera receives FDA de novo authorization for pros...

2 months ago 47

Artera gets FDA de novo nod for AI prostate cancer prognosis tool

Artera gets FDA de novo nod for AI prostate cancer...

2 months ago 42

Timothy McClure, MD, highlights data on IRE for prostate tissue ablation

Timothy McClure, MD, highlights data on IRE for pr...

2 months ago 36

Memorial Health offering free prostate cancer screenings

Memorial Health offering free prostate cancer scre...

2 months ago 32

Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Market Analysis, Emerging Therapies, Trends and Forecast

Metastatic Castration-Sensitive Prostate Cancer (m...

2 months ago 44